Harold Bays

Statistics

Publications

205

Citations

26.5K

H-Index

Active since

1997

Affiliations

Louisville Metabolic and Atherosclerosis Research Center(Current)

Baylor College of Medicine

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Louisville

Houston Methodist

Harold Bays is an author at Louisville Metabolic and Atherosclerosis Research Center specializing in pharmacotherapy, clinical pharmacology, and pharmacology.

ORCID

Publications per year

1997–2025

205

Publications

205

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)

Peter H. Jones, Michael H. Davidson, Evan A. Stein et al. · The American Journal of Cardiology · 2003 · 1.4K citations

Pharmacy, Cardiology, Pharmacotherapy +14

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies et al. · JAMA · 2021 · 1.2K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

Steven R. Smith, Neil J. Weissman, Christen M. Anderson et al. · New England Journal of Medicine · 2010 · 912 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

Steven E. Nissen, A. Michael Lincoff, Danielle M. Brennan et al. · New England Journal of Medicine · 2023 · 875 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 205